PureTech Health plc (OTCMKTS:PTCHF) Short Interest Down 29.1% in April

PureTech Health plc (OTCMKTS:PTCHF) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 48,500 shares, a decrease of 29.1% from the March 31st total of 68,400 shares. Based on an average trading volume of 6,600 shares, the days-to-cover ratio is presently 7.3 days.

PureTech Health Stock Performance

OTCMKTS:PTCHF remained flat at $2.70 during trading hours on Monday. The firm has a fifty day moving average price of $2.64 and a 200 day moving average price of $2.34. PureTech Health has a 12 month low of $1.69 and a 12 month high of $3.10.

About PureTech Health

PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.